How is lung and heart function checked in muscular dystrophy and myopathy? 

Muscular dystrophies and myopathies primarily affect the voluntary muscles used for movement, but they can also impact the vital involuntary muscles that support the heart and respiratory system. Because the heart is a muscle itself and the lungs rely on the diaphragm and chest wall muscles to breathe, regular monitoring of these organs is a standard part of neuromuscular care in the United Kingdom. Early detection of changes in heart or lung function allows specialist teams to provide proactive support, ensuring that patients maintain the best possible health. In the UK, these checks are coordinated through specialist centres to provide a comprehensive view of how a muscle condition is affecting the whole body. 

What We’ll Discuss in This Article 

• The clinical link between muscle disorders and heart and lung health. 

• Common tests used to monitor respiratory strength, such as spirometry. 

• How specialists check the electrical and structural health of the heart. 

• The signs and symptoms that indicate a need for urgent review. 

• The frequency of routine monitoring for different muscle conditions. 

• The role of the multidisciplinary team in providing cardiac and respiratory support. 

Monitoring heart and lung function is essential in muscular dystrophy and myopathy because the conditions can weaken the cardiac muscle and the respiratory muscles responsible for breathing. Muscular dystrophies are a group of inherited genetic conditions that gradually cause the muscles to weaken, leading to an increasing level of disability and potential complications for vital organs. While the impact on these organs varies significantly depending on the specific type of muscle disorder, UK specialists prioritise regular screenings to catch any changes before they lead to serious symptoms. By using a range of non-invasive tests, healthcare teams can assess how well the heart is pumping and how effectively the lungs are moving air, allowing for early intervention when necessary. 

Assessing Respiratory Function and Lung Strength 

Lung function is checked primarily through breathing tests that measure the strength of the muscles used for inhalation and exhalation, rather than the health of the lung tissue itself. Because myopathy and dystrophy affect the diaphragm and the intercostal muscles between the ribs, the lungs may not be able to expand fully, leading to a shallow breathing pattern. Specialists use spirometry and peak flow tests to measure the volume of air a person can hold and the force with which they can blow it out. 

Another common assessment is the measurement of Forced Vital Capacity (FVC), which is the total amount of air a person can exhale after taking the deepest breath possible. In many muscle conditions, the FVC is monitored closely over time to track any gradual decline in respiratory strength. If the breathing muscles become weak, it can lead to issues such as a poor cough reflex or breathlessness during sleep. Clinical guidance in the UK emphasises the importance of regular respiratory monitoring for individuals with neuromuscular conditions to prevent complications like chest infections. 

Monitoring Heart Structure and Rhythm 

Heart function is assessed using tests that look at both the electrical signals of the heart and its physical structure, as some muscle disorders can cause the heart muscle to thicken or become weak. An Electrocardiogram (ECG) is a common first step, involving small sensors attached to the skin to record the heart’s electrical activity. This test helps identify any irregular heart rhythms, known as arrhythmias, which can occur if the genetic mutation affects the heart’s internal wiring. 

To see the physical structure of the heart, specialists use an Echocardiogram (Echo), which is an ultrasound scan of the heart. This allows the doctor to see the heart valves in action and measure how effectively the heart is pumping blood around the body. In some cases, a Cardiac MRI may be used to provide even more detailed images of the heart muscle tissue. Because cardiac involvement can sometimes occur without any obvious symptoms like chest pain, these regular screenings are vital for patients with specific types of dystrophy, such as Duchenne or myotonic dystrophy. 

Test Type	Primary Purpose	What it Detects
Spirometry / FVC	Measures lung volume and force.	Weakness in the diaphragm and chest muscles.
Pulse Oximetry	Measures oxygen levels in the blood.	Ineffective breathing during the day or night.
ECG	Records the heart’s electrical rhythm.	Irregular heartbeats or conduction issues.
Echocardiogram	Ultrasound of the heart structure.	Weakening of the heart pump or valve issues.
Sleep Study	Monitors breathing overnight.	Sleep apnoea or nocturnal hypoventilation.

Recognising Symptoms of Organ Involvement 

While routine clinical tests are essential, patients and families are also taught to recognise physical signs that may indicate the heart or lungs are struggling. Symptoms of respiratory weakness often appear first during the night or upon waking in the morning. A person might experience morning headaches, feel unrefreshed after a full night’s sleep, or frequent waking during the night. These can be signs of nocturnal hypoventilation, where the breathing is too shallow during sleep to properly clear carbon dioxide from the body. 

Cardiac symptoms might be more subtle in people with limited mobility, as they may not exert themselves enough to feel typical breathlessness. Instead, signs could include persistent fatigue, swelling in the ankles or legs, or a sensation of a racing or fluttering heart. Because these symptoms can develop gradually, they are often discussed in detail during annual or six-monthly reviews at specialist neuromuscular centres. Any new or worsening symptoms should be reported to the medical team promptly to determine if additional testing is required. 

The Role of the Multidisciplinary Team 

In the UK, the monitoring of heart and lung function is a coordinated effort involving neurologists, cardiologists, and respiratory physicians. This multidisciplinary approach ensures that all aspects of a patient’s health are considered, rather than looking at the muscles in isolation. For example, if respiratory tests show a decline in lung volume, the respiratory team may introduce supportive treatments such as non-invasive ventilation (NIV), which uses a mask to help the patient breathe more deeply at night. 

Similarly, if an echocardiogram shows that the heart muscle is beginning to weaken, a cardiologist may prescribe medications such as ACE inhibitors or beta-blockers. These drugs can help protect the heart and reduce the workload on the cardiac muscle, often starting even before the patient feels any symptoms. This proactive management is a hallmark of UK neuromuscular care, aiming to extend the health and function of vital organs for as long as possible. Specialist neuromuscular centres provide a coordinated hub for cardiac and respiratory screening, ensuring that patients have access to expert advice tailored to their specific muscle condition. 

Conclusion 

Lung and heart function are checked in muscular dystrophy and myopathy through a series of regular, non-invasive tests like spirometry, ECGs, and echocardiograms. These screenings are vital because muscle disorders can impact the vital muscles responsible for breathing and blood circulation. By identifying changes early within the UK’s specialist care framework, healthcare teams can provide targeted support to protect these organs. Regular monitoring ensures that patients receive the most appropriate care to maintain their long-term well-being. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This evidence-based guide adheres to NHS and NICE clinical standards for the management of neuromuscular conditions. The content was authored by the Medical Content Team and reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine, surgery, and emergency care. Dr. Petrov has extensive experience in clinical settings and contributes to patient-focused health education to ensure readers receive accurate and safe information regarding vital organ monitoring.